Global Prescription Weight Loss Pills Supply, Demand and Key Producers, 2023-2029

Page: 106

Published Date: 03 Aug 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The global Prescription Weight Loss Pills market size is expected to reach $ 2259 million by 2029, rising at a market growth of 10.0% CAGR during the forecast period (2023-2029).

Rising conditions such as obesity, cardiovascular diseases, diabetes, and hypertension are increasing the revenue share of the global weight loss drugs market. Moreover, these drugs are used to maintain a healthy body weight amid growing adoption of a healthy lifestyle, thereby driving the expansion of the market revenue.

Health care professionals use the Body Mass Index (BMI), a measure of people weight in relation to height, to define overweight and obesity. People who have a BMI between 25 and 30 are considered to be overweight. Obesity is defined as having a BMI of 30 or greater. Are overweight, obese, or severely obese, which may increase risk of developing health problems. Obesity is a chronic disease and prescription medications to treat overweight and obesity work in different ways. Prescription weight loss medicines can help obese people lose weight. They are usually prescribed by a doctor when diet and exercise alone are not working. Each of these medicines works differently. People who use these medicines may not feel as hungry. Or they may feel full after eating only a small amount of food. Another type of weight-loss medicine makes it harder for your body to absorb fat. Prescription weight loss drugs can be helpful when used in combination with a low-calorie diet and regular physical activity.

This report studies the global Prescription Weight Loss Pills production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Prescription Weight Loss Pills, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Prescription Weight Loss Pills that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Prescription Weight Loss Pills total production and demand, 2018-2029, (K Units)
Global Prescription Weight Loss Pills total production value, 2018-2029, (USD Million)
Global Prescription Weight Loss Pills production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Prescription Weight Loss Pills consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Prescription Weight Loss Pills domestic production, consumption, key domestic manufacturers and share
Global Prescription Weight Loss Pills production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Prescription Weight Loss Pills production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Prescription Weight Loss Pills production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).

This reports profiles key players in the global Prescription Weight Loss Pills market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Currax Pharmaceuticals (Contrave), VIVUS (Qsymia), Novo Nordisk A/S, Rhythm Pharmaceuticals (Imcivree), Eli Lilly and Company (TRICARE), CHEPLAPHARM (Xenical), Pfizer, Teva Pharmaceutical (Actavis) and Haleon Group (alli), etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Prescription Weight Loss Pills market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Prescription Weight Loss Pills Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Prescription Weight Loss Pills Market, Segmentation by Type
Oral Tablets
Oral Capsules
Injections

Global Prescription Weight Loss Pills Market, Segmentation by Application
Hospital
Pharmacy

Companies Profiled:
Currax Pharmaceuticals (Contrave)
VIVUS (Qsymia)
Novo Nordisk A/S
Rhythm Pharmaceuticals (Imcivree)
Eli Lilly and Company (TRICARE)
CHEPLAPHARM (Xenical)
Pfizer
Teva Pharmaceutical (Actavis)
Haleon Group (alli)
Sanofi (Adlyxin)
AstraZeneca (BYDUREON BCise)

Key Questions Answered
1. How big is the global Prescription Weight Loss Pills market?
2. What is the demand of the global Prescription Weight Loss Pills market?
3. What is the year over year growth of the global Prescription Weight Loss Pills market?
4. What is the production and production value of the global Prescription Weight Loss Pills market?
5. Who are the key producers in the global Prescription Weight Loss Pills market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Prescription Weight Loss Pills Introduction
    1.2 World Prescription Weight Loss Pills Supply & Forecast
        1.2.1 World Prescription Weight Loss Pills Production Value (2018 & 2022 & 2029)
        1.2.2 World Prescription Weight Loss Pills Production (2018-2029)
        1.2.3 World Prescription Weight Loss Pills Pricing Trends (2018-2029)
    1.3 World Prescription Weight Loss Pills Production by Region (Based on Production Site)
        1.3.1 World Prescription Weight Loss Pills Production Value by Region (2018-2029)
        1.3.2 World Prescription Weight Loss Pills Production by Region (2018-2029)
        1.3.3 World Prescription Weight Loss Pills Average Price by Region (2018-2029)
        1.3.4 North America Prescription Weight Loss Pills Production (2018-2029)
        1.3.5 Europe Prescription Weight Loss Pills Production (2018-2029)
        1.3.6 China Prescription Weight Loss Pills Production (2018-2029)
        1.3.7 Japan Prescription Weight Loss Pills Production (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Prescription Weight Loss Pills Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Prescription Weight Loss Pills Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
    2.1 World Prescription Weight Loss Pills Demand (2018-2029)
    2.2 World Prescription Weight Loss Pills Consumption by Region
        2.2.1 World Prescription Weight Loss Pills Consumption by Region (2018-2023)
        2.2.2 World Prescription Weight Loss Pills Consumption Forecast by Region (2024-2029)
    2.3 United States Prescription Weight Loss Pills Consumption (2018-2029)
    2.4 China Prescription Weight Loss Pills Consumption (2018-2029)
    2.5 Europe Prescription Weight Loss Pills Consumption (2018-2029)
    2.6 Japan Prescription Weight Loss Pills Consumption (2018-2029)
    2.7 South Korea Prescription Weight Loss Pills Consumption (2018-2029)
    2.8 ASEAN Prescription Weight Loss Pills Consumption (2018-2029)
    2.9 India Prescription Weight Loss Pills Consumption (2018-2029)

3 World Prescription Weight Loss Pills Manufacturers Competitive Analysis
    3.1 World Prescription Weight Loss Pills Production Value by Manufacturer (2018-2023)
    3.2 World Prescription Weight Loss Pills Production by Manufacturer (2018-2023)
    3.3 World Prescription Weight Loss Pills Average Price by Manufacturer (2018-2023)
    3.4 Prescription Weight Loss Pills Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global Prescription Weight Loss Pills Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for Prescription Weight Loss Pills in 2022
        3.5.3 Global Concentration Ratios (CR8) for Prescription Weight Loss Pills in 2022
    3.6 Prescription Weight Loss Pills Market: Overall Company Footprint Analysis
        3.6.1 Prescription Weight Loss Pills Market: Region Footprint
        3.6.2 Prescription Weight Loss Pills Market: Company Product Type Footprint
        3.6.3 Prescription Weight Loss Pills Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: Prescription Weight Loss Pills Production Value Comparison
        4.1.1 United States VS China: Prescription Weight Loss Pills Production Value Comparison (2018 & 2022 & 2029)
        4.1.2 United States VS China: Prescription Weight Loss Pills Production Value Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States VS China: Prescription Weight Loss Pills Production Comparison
        4.2.1 United States VS China: Prescription Weight Loss Pills Production Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Prescription Weight Loss Pills Production Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States VS China: Prescription Weight Loss Pills Consumption Comparison
        4.3.1 United States VS China: Prescription Weight Loss Pills Consumption Comparison (2018 & 2022 & 2029)
        4.3.2 United States VS China: Prescription Weight Loss Pills Consumption Market Share Comparison (2018 & 2022 & 2029)
    4.4 United States Based Prescription Weight Loss Pills Manufacturers and Market Share, 2018-2023
        4.4.1 United States Based Prescription Weight Loss Pills Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers Prescription Weight Loss Pills Production Value (2018-2023)
        4.4.3 United States Based Manufacturers Prescription Weight Loss Pills Production (2018-2023)
    4.5 China Based Prescription Weight Loss Pills Manufacturers and Market Share
        4.5.1 China Based Prescription Weight Loss Pills Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers Prescription Weight Loss Pills Production Value (2018-2023)
        4.5.3 China Based Manufacturers Prescription Weight Loss Pills Production (2018-2023)
    4.6 Rest of World Based Prescription Weight Loss Pills Manufacturers and Market Share, 2018-2023
        4.6.1 Rest of World Based Prescription Weight Loss Pills Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers Prescription Weight Loss Pills Production Value (2018-2023)
        4.6.3 Rest of World Based Manufacturers Prescription Weight Loss Pills Production (2018-2023)

5 Market Analysis by Type
    5.1 World Prescription Weight Loss Pills Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Oral Tablets
        5.2.2 Oral Capsules
        5.2.3 Injections
    5.3 Market Segment by Type
        5.3.1 World Prescription Weight Loss Pills Production by Type (2018-2029)
        5.3.2 World Prescription Weight Loss Pills Production Value by Type (2018-2029)
        5.3.3 World Prescription Weight Loss Pills Average Price by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Prescription Weight Loss Pills Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Hospital
        6.2.2 Pharmacy
    6.3 Market Segment by Application
        6.3.1 World Prescription Weight Loss Pills Production by Application (2018-2029)
        6.3.2 World Prescription Weight Loss Pills Production Value by Application (2018-2029)
        6.3.3 World Prescription Weight Loss Pills Average Price by Application (2018-2029)

7 Company Profiles
    7.1 Currax Pharmaceuticals (Contrave)
        7.1.1 Currax Pharmaceuticals (Contrave) Details
        7.1.2 Currax Pharmaceuticals (Contrave) Major Business
        7.1.3 Currax Pharmaceuticals (Contrave) Prescription Weight Loss Pills Product and Services
        7.1.4 Currax Pharmaceuticals (Contrave) Prescription Weight Loss Pills Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.1.5 Currax Pharmaceuticals (Contrave) Recent Developments/Updates
        7.1.6 Currax Pharmaceuticals (Contrave) Competitive Strengths & Weaknesses
    7.2 VIVUS (Qsymia)
        7.2.1 VIVUS (Qsymia) Details
        7.2.2 VIVUS (Qsymia) Major Business
        7.2.3 VIVUS (Qsymia) Prescription Weight Loss Pills Product and Services
        7.2.4 VIVUS (Qsymia) Prescription Weight Loss Pills Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.2.5 VIVUS (Qsymia) Recent Developments/Updates
        7.2.6 VIVUS (Qsymia) Competitive Strengths & Weaknesses
    7.3 Novo Nordisk A/S
        7.3.1 Novo Nordisk A/S Details
        7.3.2 Novo Nordisk A/S Major Business
        7.3.3 Novo Nordisk A/S Prescription Weight Loss Pills Product and Services
        7.3.4 Novo Nordisk A/S Prescription Weight Loss Pills Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.3.5 Novo Nordisk A/S Recent Developments/Updates
        7.3.6 Novo Nordisk A/S Competitive Strengths & Weaknesses
    7.4 Rhythm Pharmaceuticals (Imcivree)
        7.4.1 Rhythm Pharmaceuticals (Imcivree) Details
        7.4.2 Rhythm Pharmaceuticals (Imcivree) Major Business
        7.4.3 Rhythm Pharmaceuticals (Imcivree) Prescription Weight Loss Pills Product and Services
        7.4.4 Rhythm Pharmaceuticals (Imcivree) Prescription Weight Loss Pills Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.4.5 Rhythm Pharmaceuticals (Imcivree) Recent Developments/Updates
        7.4.6 Rhythm Pharmaceuticals (Imcivree) Competitive Strengths & Weaknesses
    7.5 Eli Lilly and Company (TRICARE)
        7.5.1 Eli Lilly and Company (TRICARE) Details
        7.5.2 Eli Lilly and Company (TRICARE) Major Business
        7.5.3 Eli Lilly and Company (TRICARE) Prescription Weight Loss Pills Product and Services
        7.5.4 Eli Lilly and Company (TRICARE) Prescription Weight Loss Pills Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.5.5 Eli Lilly and Company (TRICARE) Recent Developments/Updates
        7.5.6 Eli Lilly and Company (TRICARE) Competitive Strengths & Weaknesses
    7.6 CHEPLAPHARM (Xenical)
        7.6.1 CHEPLAPHARM (Xenical) Details
        7.6.2 CHEPLAPHARM (Xenical) Major Business
        7.6.3 CHEPLAPHARM (Xenical) Prescription Weight Loss Pills Product and Services
        7.6.4 CHEPLAPHARM (Xenical) Prescription Weight Loss Pills Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.6.5 CHEPLAPHARM (Xenical) Recent Developments/Updates
        7.6.6 CHEPLAPHARM (Xenical) Competitive Strengths & Weaknesses
    7.7 Pfizer
        7.7.1 Pfizer Details
        7.7.2 Pfizer Major Business
        7.7.3 Pfizer Prescription Weight Loss Pills Product and Services
        7.7.4 Pfizer Prescription Weight Loss Pills Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.7.5 Pfizer Recent Developments/Updates
        7.7.6 Pfizer Competitive Strengths & Weaknesses
    7.8 Teva Pharmaceutical (Actavis)
        7.8.1 Teva Pharmaceutical (Actavis) Details
        7.8.2 Teva Pharmaceutical (Actavis) Major Business
        7.8.3 Teva Pharmaceutical (Actavis) Prescription Weight Loss Pills Product and Services
        7.8.4 Teva Pharmaceutical (Actavis) Prescription Weight Loss Pills Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.8.5 Teva Pharmaceutical (Actavis) Recent Developments/Updates
        7.8.6 Teva Pharmaceutical (Actavis) Competitive Strengths & Weaknesses
    7.9 Haleon Group (alli)
        7.9.1 Haleon Group (alli) Details
        7.9.2 Haleon Group (alli) Major Business
        7.9.3 Haleon Group (alli) Prescription Weight Loss Pills Product and Services
        7.9.4 Haleon Group (alli) Prescription Weight Loss Pills Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.9.5 Haleon Group (alli) Recent Developments/Updates
        7.9.6 Haleon Group (alli) Competitive Strengths & Weaknesses
    7.10 Sanofi (Adlyxin)
        7.10.1 Sanofi (Adlyxin) Details
        7.10.2 Sanofi (Adlyxin) Major Business
        7.10.3 Sanofi (Adlyxin) Prescription Weight Loss Pills Product and Services
        7.10.4 Sanofi (Adlyxin) Prescription Weight Loss Pills Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.10.5 Sanofi (Adlyxin) Recent Developments/Updates
        7.10.6 Sanofi (Adlyxin) Competitive Strengths & Weaknesses
    7.11 AstraZeneca (BYDUREON BCise)
        7.11.1 AstraZeneca (BYDUREON BCise) Details
        7.11.2 AstraZeneca (BYDUREON BCise) Major Business
        7.11.3 AstraZeneca (BYDUREON BCise) Prescription Weight Loss Pills Product and Services
        7.11.4 AstraZeneca (BYDUREON BCise) Prescription Weight Loss Pills Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.11.5 AstraZeneca (BYDUREON BCise) Recent Developments/Updates
        7.11.6 AstraZeneca (BYDUREON BCise) Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Prescription Weight Loss Pills Industry Chain
    8.2 Prescription Weight Loss Pills Upstream Analysis
        8.2.1 Prescription Weight Loss Pills Core Raw Materials
        8.2.2 Main Manufacturers of Prescription Weight Loss Pills Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 Prescription Weight Loss Pills Production Mode
    8.6 Prescription Weight Loss Pills Procurement Model
    8.7 Prescription Weight Loss Pills Industry Sales Model and Sales Channels
        8.7.1 Prescription Weight Loss Pills Sales Model
        8.7.2 Prescription Weight Loss Pills Typical Customers

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Prescription Weight Loss Pills Production Value by Region (2018, 2022 and 2029) & (USD Million)
    Table 2. World Prescription Weight Loss Pills Production Value by Region (2018-2023) & (USD Million)
    Table 3. World Prescription Weight Loss Pills Production Value by Region (2024-2029) & (USD Million)
    Table 4. World Prescription Weight Loss Pills Production Value Market Share by Region (2018-2023)
    Table 5. World Prescription Weight Loss Pills Production Value Market Share by Region (2024-2029)
    Table 6. World Prescription Weight Loss Pills Production by Region (2018-2023) & (K Units)
    Table 7. World Prescription Weight Loss Pills Production by Region (2024-2029) & (K Units)
    Table 8. World Prescription Weight Loss Pills Production Market Share by Region (2018-2023)
    Table 9. World Prescription Weight Loss Pills Production Market Share by Region (2024-2029)
    Table 10. World Prescription Weight Loss Pills Average Price by Region (2018-2023) & (US$/Unit)
    Table 11. World Prescription Weight Loss Pills Average Price by Region (2024-2029) & (US$/Unit)
    Table 12. Prescription Weight Loss Pills Major Market Trends
    Table 13. World Prescription Weight Loss Pills Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
    Table 14. World Prescription Weight Loss Pills Consumption by Region (2018-2023) & (K Units)
    Table 15. World Prescription Weight Loss Pills Consumption Forecast by Region (2024-2029) & (K Units)
    Table 16. World Prescription Weight Loss Pills Production Value by Manufacturer (2018-2023) & (USD Million)
    Table 17. Production Value Market Share of Key Prescription Weight Loss Pills Producers in 2022
    Table 18. World Prescription Weight Loss Pills Production by Manufacturer (2018-2023) & (K Units)
    Table 19. Production Market Share of Key Prescription Weight Loss Pills Producers in 2022
    Table 20. World Prescription Weight Loss Pills Average Price by Manufacturer (2018-2023) & (US$/Unit)
    Table 21. Global Prescription Weight Loss Pills Company Evaluation Quadrant
    Table 22. World Prescription Weight Loss Pills Industry Rank of Major Manufacturers, Based on Production Value in 2022
    Table 23. Head Office and Prescription Weight Loss Pills Production Site of Key Manufacturer
    Table 24. Prescription Weight Loss Pills Market: Company Product Type Footprint
    Table 25. Prescription Weight Loss Pills Market: Company Product Application Footprint
    Table 26. Prescription Weight Loss Pills Competitive Factors
    Table 27. Prescription Weight Loss Pills New Entrant and Capacity Expansion Plans
    Table 28. Prescription Weight Loss Pills Mergers & Acquisitions Activity
    Table 29. United States VS China Prescription Weight Loss Pills Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 30. United States VS China Prescription Weight Loss Pills Production Comparison, (2018 & 2022 & 2029) & (K Units)
    Table 31. United States VS China Prescription Weight Loss Pills Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
    Table 32. United States Based Prescription Weight Loss Pills Manufacturers, Headquarters and Production Site (States, Country)
    Table 33. United States Based Manufacturers Prescription Weight Loss Pills Production Value, (2018-2023) & (USD Million)
    Table 34. United States Based Manufacturers Prescription Weight Loss Pills Production Value Market Share (2018-2023)
    Table 35. United States Based Manufacturers Prescription Weight Loss Pills Production (2018-2023) & (K Units)
    Table 36. United States Based Manufacturers Prescription Weight Loss Pills Production Market Share (2018-2023)
    Table 37. China Based Prescription Weight Loss Pills Manufacturers, Headquarters and Production Site (Province, Country)
    Table 38. China Based Manufacturers Prescription Weight Loss Pills Production Value, (2018-2023) & (USD Million)
    Table 39. China Based Manufacturers Prescription Weight Loss Pills Production Value Market Share (2018-2023)
    Table 40. China Based Manufacturers Prescription Weight Loss Pills Production (2018-2023) & (K Units)
    Table 41. China Based Manufacturers Prescription Weight Loss Pills Production Market Share (2018-2023)
    Table 42. Rest of World Based Prescription Weight Loss Pills Manufacturers, Headquarters and Production Site (States, Country)
    Table 43. Rest of World Based Manufacturers Prescription Weight Loss Pills Production Value, (2018-2023) & (USD Million)
    Table 44. Rest of World Based Manufacturers Prescription Weight Loss Pills Production Value Market Share (2018-2023)
    Table 45. Rest of World Based Manufacturers Prescription Weight Loss Pills Production (2018-2023) & (K Units)
    Table 46. Rest of World Based Manufacturers Prescription Weight Loss Pills Production Market Share (2018-2023)
    Table 47. World Prescription Weight Loss Pills Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 48. World Prescription Weight Loss Pills Production by Type (2018-2023) & (K Units)
    Table 49. World Prescription Weight Loss Pills Production by Type (2024-2029) & (K Units)
    Table 50. World Prescription Weight Loss Pills Production Value by Type (2018-2023) & (USD Million)
    Table 51. World Prescription Weight Loss Pills Production Value by Type (2024-2029) & (USD Million)
    Table 52. World Prescription Weight Loss Pills Average Price by Type (2018-2023) & (US$/Unit)
    Table 53. World Prescription Weight Loss Pills Average Price by Type (2024-2029) & (US$/Unit)
    Table 54. World Prescription Weight Loss Pills Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 55. World Prescription Weight Loss Pills Production by Application (2018-2023) & (K Units)
    Table 56. World Prescription Weight Loss Pills Production by Application (2024-2029) & (K Units)
    Table 57. World Prescription Weight Loss Pills Production Value by Application (2018-2023) & (USD Million)
    Table 58. World Prescription Weight Loss Pills Production Value by Application (2024-2029) & (USD Million)
    Table 59. World Prescription Weight Loss Pills Average Price by Application (2018-2023) & (US$/Unit)
    Table 60. World Prescription Weight Loss Pills Average Price by Application (2024-2029) & (US$/Unit)
    Table 61. Currax Pharmaceuticals (Contrave) Basic Information, Manufacturing Base and Competitors
    Table 62. Currax Pharmaceuticals (Contrave) Major Business
    Table 63. Currax Pharmaceuticals (Contrave) Prescription Weight Loss Pills Product and Services
    Table 64. Currax Pharmaceuticals (Contrave) Prescription Weight Loss Pills Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 65. Currax Pharmaceuticals (Contrave) Recent Developments/Updates
    Table 66. Currax Pharmaceuticals (Contrave) Competitive Strengths & Weaknesses
    Table 67. VIVUS (Qsymia) Basic Information, Manufacturing Base and Competitors
    Table 68. VIVUS (Qsymia) Major Business
    Table 69. VIVUS (Qsymia) Prescription Weight Loss Pills Product and Services
    Table 70. VIVUS (Qsymia) Prescription Weight Loss Pills Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 71. VIVUS (Qsymia) Recent Developments/Updates
    Table 72. VIVUS (Qsymia) Competitive Strengths & Weaknesses
    Table 73. Novo Nordisk A/S Basic Information, Manufacturing Base and Competitors
    Table 74. Novo Nordisk A/S Major Business
    Table 75. Novo Nordisk A/S Prescription Weight Loss Pills Product and Services
    Table 76. Novo Nordisk A/S Prescription Weight Loss Pills Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 77. Novo Nordisk A/S Recent Developments/Updates
    Table 78. Novo Nordisk A/S Competitive Strengths & Weaknesses
    Table 79. Rhythm Pharmaceuticals (Imcivree) Basic Information, Manufacturing Base and Competitors
    Table 80. Rhythm Pharmaceuticals (Imcivree) Major Business
    Table 81. Rhythm Pharmaceuticals (Imcivree) Prescription Weight Loss Pills Product and Services
    Table 82. Rhythm Pharmaceuticals (Imcivree) Prescription Weight Loss Pills Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 83. Rhythm Pharmaceuticals (Imcivree) Recent Developments/Updates
    Table 84. Rhythm Pharmaceuticals (Imcivree) Competitive Strengths & Weaknesses
    Table 85. Eli Lilly and Company (TRICARE) Basic Information, Manufacturing Base and Competitors
    Table 86. Eli Lilly and Company (TRICARE) Major Business
    Table 87. Eli Lilly and Company (TRICARE) Prescription Weight Loss Pills Product and Services
    Table 88. Eli Lilly and Company (TRICARE) Prescription Weight Loss Pills Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 89. Eli Lilly and Company (TRICARE) Recent Developments/Updates
    Table 90. Eli Lilly and Company (TRICARE) Competitive Strengths & Weaknesses
    Table 91. CHEPLAPHARM (Xenical) Basic Information, Manufacturing Base and Competitors
    Table 92. CHEPLAPHARM (Xenical) Major Business
    Table 93. CHEPLAPHARM (Xenical) Prescription Weight Loss Pills Product and Services
    Table 94. CHEPLAPHARM (Xenical) Prescription Weight Loss Pills Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 95. CHEPLAPHARM (Xenical) Recent Developments/Updates
    Table 96. CHEPLAPHARM (Xenical) Competitive Strengths & Weaknesses
    Table 97. Pfizer Basic Information, Manufacturing Base and Competitors
    Table 98. Pfizer Major Business
    Table 99. Pfizer Prescription Weight Loss Pills Product and Services
    Table 100. Pfizer Prescription Weight Loss Pills Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 101. Pfizer Recent Developments/Updates
    Table 102. Pfizer Competitive Strengths & Weaknesses
    Table 103. Teva Pharmaceutical (Actavis) Basic Information, Manufacturing Base and Competitors
    Table 104. Teva Pharmaceutical (Actavis) Major Business
    Table 105. Teva Pharmaceutical (Actavis) Prescription Weight Loss Pills Product and Services
    Table 106. Teva Pharmaceutical (Actavis) Prescription Weight Loss Pills Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 107. Teva Pharmaceutical (Actavis) Recent Developments/Updates
    Table 108. Teva Pharmaceutical (Actavis) Competitive Strengths & Weaknesses
    Table 109. Haleon Group (alli) Basic Information, Manufacturing Base and Competitors
    Table 110. Haleon Group (alli) Major Business
    Table 111. Haleon Group (alli) Prescription Weight Loss Pills Product and Services
    Table 112. Haleon Group (alli) Prescription Weight Loss Pills Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 113. Haleon Group (alli) Recent Developments/Updates
    Table 114. Haleon Group (alli) Competitive Strengths & Weaknesses
    Table 115. Sanofi (Adlyxin) Basic Information, Manufacturing Base and Competitors
    Table 116. Sanofi (Adlyxin) Major Business
    Table 117. Sanofi (Adlyxin) Prescription Weight Loss Pills Product and Services
    Table 118. Sanofi (Adlyxin) Prescription Weight Loss Pills Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 119. Sanofi (Adlyxin) Recent Developments/Updates
    Table 120. AstraZeneca (BYDUREON BCise) Basic Information, Manufacturing Base and Competitors
    Table 121. AstraZeneca (BYDUREON BCise) Major Business
    Table 122. AstraZeneca (BYDUREON BCise) Prescription Weight Loss Pills Product and Services
    Table 123. AstraZeneca (BYDUREON BCise) Prescription Weight Loss Pills Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 124. Global Key Players of Prescription Weight Loss Pills Upstream (Raw Materials)
    Table 125. Prescription Weight Loss Pills Typical Customers
    Table 126. Prescription Weight Loss Pills Typical Distributors
List of Figure
    Figure 1. Prescription Weight Loss Pills Picture
    Figure 2. World Prescription Weight Loss Pills Production Value: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Prescription Weight Loss Pills Production Value and Forecast (2018-2029) & (USD Million)
    Figure 4. World Prescription Weight Loss Pills Production (2018-2029) & (K Units)
    Figure 5. World Prescription Weight Loss Pills Average Price (2018-2029) & (US$/Unit)
    Figure 6. World Prescription Weight Loss Pills Production Value Market Share by Region (2018-2029)
    Figure 7. World Prescription Weight Loss Pills Production Market Share by Region (2018-2029)
    Figure 8. North America Prescription Weight Loss Pills Production (2018-2029) & (K Units)
    Figure 9. Europe Prescription Weight Loss Pills Production (2018-2029) & (K Units)
    Figure 10. China Prescription Weight Loss Pills Production (2018-2029) & (K Units)
    Figure 11. Japan Prescription Weight Loss Pills Production (2018-2029) & (K Units)
    Figure 12. Prescription Weight Loss Pills Market Drivers
    Figure 13. Factors Affecting Demand
    Figure 14. World Prescription Weight Loss Pills Consumption (2018-2029) & (K Units)
    Figure 15. World Prescription Weight Loss Pills Consumption Market Share by Region (2018-2029)
    Figure 16. United States Prescription Weight Loss Pills Consumption (2018-2029) & (K Units)
    Figure 17. China Prescription Weight Loss Pills Consumption (2018-2029) & (K Units)
    Figure 18. Europe Prescription Weight Loss Pills Consumption (2018-2029) & (K Units)
    Figure 19. Japan Prescription Weight Loss Pills Consumption (2018-2029) & (K Units)
    Figure 20. South Korea Prescription Weight Loss Pills Consumption (2018-2029) & (K Units)
    Figure 21. ASEAN Prescription Weight Loss Pills Consumption (2018-2029) & (K Units)
    Figure 22. India Prescription Weight Loss Pills Consumption (2018-2029) & (K Units)
    Figure 23. Producer Shipments of Prescription Weight Loss Pills by Manufacturer Revenue ($MM) and Market Share (%): 2022
    Figure 24. Global Four-firm Concentration Ratios (CR4) for Prescription Weight Loss Pills Markets in 2022
    Figure 25. Global Four-firm Concentration Ratios (CR8) for Prescription Weight Loss Pills Markets in 2022
    Figure 26. United States VS China: Prescription Weight Loss Pills Production Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 27. United States VS China: Prescription Weight Loss Pills Production Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Prescription Weight Loss Pills Consumption Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. United States Based Manufacturers Prescription Weight Loss Pills Production Market Share 2022
    Figure 30. China Based Manufacturers Prescription Weight Loss Pills Production Market Share 2022
    Figure 31. Rest of World Based Manufacturers Prescription Weight Loss Pills Production Market Share 2022
    Figure 32. World Prescription Weight Loss Pills Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 33. World Prescription Weight Loss Pills Production Value Market Share by Type in 2022
    Figure 34. Oral Tablets
    Figure 35. Oral Capsules
    Figure 36. Injections
    Figure 37. World Prescription Weight Loss Pills Production Market Share by Type (2018-2029)
    Figure 38. World Prescription Weight Loss Pills Production Value Market Share by Type (2018-2029)
    Figure 39. World Prescription Weight Loss Pills Average Price by Type (2018-2029) & (US$/Unit)
    Figure 40. World Prescription Weight Loss Pills Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Figure 41. World Prescription Weight Loss Pills Production Value Market Share by Application in 2022
    Figure 42. Hospital
    Figure 43. Pharmacy
    Figure 44. World Prescription Weight Loss Pills Production Market Share by Application (2018-2029)
    Figure 45. World Prescription Weight Loss Pills Production Value Market Share by Application (2018-2029)
    Figure 46. World Prescription Weight Loss Pills Average Price by Application (2018-2029) & (US$/Unit)
    Figure 47. Prescription Weight Loss Pills Industry Chain
    Figure 48. Prescription Weight Loss Pills Procurement Model
    Figure 49. Prescription Weight Loss Pills Sales Model
    Figure 50. Prescription Weight Loss Pills Sales Channels, Direct Sales, and Distribution
    Figure 51. Methodology
    Figure 52. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Currax Pharmaceuticals (Contrave)
VIVUS (Qsymia)
Novo Nordisk A/S
Rhythm Pharmaceuticals (Imcivree)
Eli Lilly and Company (TRICARE)
CHEPLAPHARM (Xenical)
Pfizer
Teva Pharmaceutical (Actavis)
Haleon Group (alli)
Sanofi (Adlyxin)
AstraZeneca (BYDUREON BCise)

Related Reports

Global Prescription Weight Loss Pills Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Prescription Weight Loss Pills Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 03 Aug 2023

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Prescription Weight Loss Pills market size was valued at USD 1162.7 million in 2022 and is forecast to a readjusted size of USD 2259 million by 2029 with a CAGR of 10.0% during review period.

Global Prescription Weight Loss Pills Supply, Demand and Key Producers, 2024-2030

Global Prescription Weight Loss Pills Supply, Demand and Key Producers, 2024-2030

date 18 Feb 2024

date Pharma & Healthcare

The global Prescription Weight Loss Pills market size is expected to reach $ 2259 million by 2030, rising at a market growth of 10.0% CAGR during the forecast period (2024-2030).

Product Tags

Prescription Weight Loss Pills

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>